But awareness of cancer-associated thrombosis and preventable measures is remarkably low throughout Europe, according to a recent survey from the European Cancer Patient Coalition (ECPC) carried out in six European Union countries, in over 1,000 cancer patients. British chemotherapy patients, in particular, have indicated that they have limited knowledge about cancer-associated thormbosis and received no information about the condition, with diagnosis and treatment of the condition often delayed.
The report states that if a cancer patient requires anticoagulation treatment, it is important to offer a treatment choice, informed by a discussion